Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of three compounds (viability/apoptosis dataset 2 of 2) - Dataset (ID:20273)

Filter results: >>>>
  • Page 1 of 75
  • 1 to 25 of 1860 records
Cell Small Molecule 1 Small Molecule 2 Small Molecule 3 Small Mol 1 Concentration Small Mol 2 Concentration Small Mol 3 Concentration Small Mol Conc Unit Time Point Time Point Unit Replicate Total Number of Cells (Nuclei) Number of Apoptotic Cells Relative Viability Mean Relative Viability Apoptosis Fraction Mean Apoptosis Fraction
A-375 Vemurafenib Trametinib JNK-IN-8 0.0000 0.0000 1.0000
uM
72
hr
3 11320 265 0.6518 0.6666 0.0234 0.0291
A-375 Vemurafenib Trametinib JNK-IN-8 0.0000 0.0000 1.0000
uM
72
hr
1 11842 391 0.6751 0.6666 0.0330 0.0291
A-375 Vemurafenib Trametinib JNK-IN-8 0.0000 0.0000 1.0000
uM
72
hr
2 11776 362 0.6729 0.6666 0.0307 0.0291
MMAC-SF Vemurafenib Trametinib Dasatinib 0.0000 0.0000 3.1600
uM
72
hr
1 1031 35 0.9423 0.7329 0.0339 0.0348
MMAC-SF Vemurafenib Trametinib Dasatinib 0.0000 0.0000 3.1600
uM
72
hr
2 875 41 0.7890 0.7329 0.0469 0.0348
MMAC-SF Vemurafenib Trametinib Dasatinib 0.0000 0.0000 3.1600
uM
72
hr
3 506 12 0.4674 0.7329 0.0237 0.0348
A-375 Vemurafenib Trametinib Saracatinib 0.0000 0.0000 1.0000
uM
72
hr
2 7768 292 0.4441 0.4663 0.0376 0.0378
A-375 Vemurafenib Trametinib Saracatinib 0.0000 0.0000 1.0000
uM
72
hr
3 7367 288 0.4205 0.4663 0.0391 0.0378
A-375 Vemurafenib Trametinib Saracatinib 0.0000 0.0000 1.0000
uM
72
hr
1 9338 344 0.5342 0.4663 0.0368 0.0378
MMAC-SF Vemurafenib Trametinib JNK-IN-8 0.0000 0.0000 0.3160
uM
72
hr
2 1390 63 1.3139 1.3106 0.0453 0.0383
MMAC-SF Vemurafenib Trametinib JNK-IN-8 0.0000 0.0000 0.3160
uM
72
hr
3 1446 46 1.3861 1.3106 0.0318 0.0383
MMAC-SF Vemurafenib Trametinib JNK-IN-8 0.0000 0.0000 0.3160
uM
72
hr
1 1293 49 1.2317 1.3106 0.0379 0.0383
A-375 Vemurafenib Trametinib Saracatinib 0.0000 0.0000 3.1600
uM
72
hr
2 6743 305 0.3824 0.3895 0.0452 0.0403
A-375 Vemurafenib Trametinib Saracatinib 0.0000 0.0000 3.1600
uM
72
hr
3 4796 182 0.2741 0.3895 0.0379 0.0403
A-375 Vemurafenib Trametinib Saracatinib 0.0000 0.0000 3.1600
uM
72
hr
1 8961 339 0.5121 0.3895 0.0378 0.0403
A-375 Vemurafenib Trametinib JNK-IN-8 0.0000 0.0000 0.3160
uM
72
hr
2 18988 841 1.0699 1.0240 0.0443 0.0404
A-375 Vemurafenib Trametinib JNK-IN-8 0.0000 0.0000 0.3160
uM
72
hr
1 15733 557 0.8947 1.0240 0.0354 0.0404
A-375 Vemurafenib Trametinib JNK-IN-8 0.0000 0.0000 0.3160
uM
72
hr
3 19598 815 1.1074 1.0240 0.0416 0.0404
MMAC-SF Vemurafenib Trametinib PF562271 0.0000 0.0000 3.1600
uM
72
hr
3 408 15 0.3398 0.4801 0.0368 0.0405
MMAC-SF Vemurafenib Trametinib PF562271 0.0000 0.0000 3.1600
uM
72
hr
2 577 29 0.4738 0.4801 0.0503 0.0405
MMAC-SF Vemurafenib Trametinib PF562271 0.0000 0.0000 3.1600
uM
72
hr
1 751 26 0.6268 0.4801 0.0346 0.0405
A-375 Vemurafenib Trametinib Dasatinib 0.0000 0.0000 3.1600
uM
72
hr
2 2717 113 0.1673 0.1595 0.0416 0.0410
A-375 Vemurafenib Trametinib Dasatinib 0.0000 0.0000 3.1600
uM
72
hr
1 3039 126 0.1872 0.1595 0.0415 0.0410
A-375 Vemurafenib Trametinib Dasatinib 0.0000 0.0000 3.1600
uM
72
hr
3 2009 80 0.1240 0.1595 0.0398 0.0410
MMAC-SF Vemurafenib Trametinib Defactinib 0.0000 0.0000 0.0000
uM
72
hr
1 1060 39 0.9858 1.0000 0.0368 0.0416
  • Page 1 of 75
  • 1 to 25 of 1860 records